USA - NASDAQ:SNWV - US80303D3052 - Common Stock
The current stock price of SNWV is 28.94 USD. In the past month the price decreased by -22.68%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 24.77 | 215.16B | ||
| ISRG | INTUITIVE SURGICAL INC | 62.05 | 191.53B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.14 | 149.24B | ||
| SYK | STRYKER CORP | 27.05 | 136.19B | ||
| MDT | MEDTRONIC PLC | 16.4 | 116.34B | ||
| BDX | BECTON DICKINSON AND CO | 12.52 | 51.22B | ||
| IDXX | IDEXX LABORATORIES INC | 52.42 | 50.36B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.08 | 48.41B | ||
| RMD | RESMED INC | 24.94 | 36.03B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.33 | 34.22B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.46 | 26.31B | ||
| STE | STERIS PLC | 24.71 | 23.21B |
SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. The company is headquartered in Eden Prairie, Minnesota and currently employs 46 full-time employees. The company went IPO on 2008-11-07. The company is a provider of wound care products. The company is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. The company applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, and aesthetic/cosmetic. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression technology to converge at precise selected targets to produce short duration compression burst and are used in both wound and orthopedic applications under the brand names dermaPACE and others.
SANUWAVE HEALTH INC
9600 W. 6Th Sstreet
Eden Prairie MINNESOTA US
Employees: 46
Phone: 19526561029
SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. The company is headquartered in Eden Prairie, Minnesota and currently employs 46 full-time employees. The company went IPO on 2008-11-07. The company is a provider of wound care products. The company is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. The company applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, and aesthetic/cosmetic. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression technology to converge at precise selected targets to produce short duration compression burst and are used in both wound and orthopedic applications under the brand names dermaPACE and others.
The current stock price of SNWV is 28.94 USD. The price increased by 3.28% in the last trading session.
SNWV does not pay a dividend.
SNWV has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on SNWV.
The outstanding short interest for SANUWAVE HEALTH INC (SNWV) is 6.15% of its float.
ChartMill assigns a fundamental rating of 3 / 10 to SNWV. SNWV may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months SNWV reported a non-GAAP Earnings per Share(EPS) of -8.55. The EPS decreased by -140.85% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -115.07% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
8 analysts have analysed SNWV and the average price target is 55.08 USD. This implies a price increase of 90.32% is expected in the next year compared to the current price of 28.94.
For the next year, analysts expect an EPS growth of 99.2% and a revenue growth 38.9% for SNWV